The effect of long-term traditional Chinese medicine treatment on disease-free survival of postoperative stage I-III lung cancer patients: a retrospective cohort study
Journal Title: Traditional Medicine Research - Year 2019, Vol 4, Issue 2
Abstract
Objective: Traditional Chinese medicine (TCM) has been extensively used as one of popular alternative therapies for several cancers. However, it remains unclear whether TCM treatment is associated with longer survival in lung cancer patients. In this study, we explored the effect of long-term TCM treatment on patients with different stages of lung cancer. Methods: All information of lung cancer patients with stage I-III disease from January 2007 to September 2015 was collected for this retrospective cohort study. Those who were treated with TCM after surgery were divided into TCM group and the others were into the non-TCM group (control group). All patients were regularly followed up by clinic appointment or phone, and all survival data were collected from databases after the last follow-up in October 2017. Results: A total of 575 patients were included in this study, with 299 patients in the TCM group and 276 in the control group. For all patients, 5-year disease-free survival (DFS) was 62.2% in TCM group and 42.1% in the control group, and 6-year DFSs were 51.8% and 35.4%, respectively (HR = 0.51, 95% CI: 0.40 to 0.66, log-rank P ≤ 0.001). For patients with stage I, 5-year DFSs were 83.7% (TCM group) and 57.5% (control group) and 6-year DFSs were 73.7% and 51.9%, respectively (HR = 0.30, 95% CI: 0.18 to 0.50, log-rank P ≤ 0.001). For patients with stage II in the TCM group and the control group, 5-year DFSs were 59.4% and 17.6% and 6-year DFSs were 44.7% and 17.6%, respectively (HR = 0.31, 95% CI: 0.19 to 0.52, log-rank P ≤ 0.001), and for patients with stage III, 5-year and 6-year DFSs in the TCM group were 18.7% and 12.5% compared with 28.4% and 20.3% in the control group (HR = 1.06, 95% CI: 0.72 to 1.56, log-rank P = 0.76). Conclusions: This study demonstrated that long-term TCM treatment as an adjuvant therapy is able to improve the DFS of postoperative stage I-III lung cancer patients, especially in patients with stage I and II disease. However, these observational findings need being validated by large sample randomized controlled trials.
Authors and Affiliations
Su-Tong Liu, Su-Fang Zhang,Kai-Qi Su, Ying-Bin Luo, Zhi-Hong Fang, Yuan Fang, Jing Xu, Jian-Chun Wu,Yan Li
Keywords
Related Articles
- EP ID EP45111
- DOI 10.12032/TMR20190225099
- Views 308
- Downloads 0
Medical workers in traditional medicine who sacrificed their lives in the battle against COVID-19 deserve to be remembered forever
China held a national day of mourning on April 4, 2020 to commemorate 3,335 victims of the COVID-19 outbreak, including medical workers who sacrificed their lives in the battle against the epidemic. April 4 was also Tomb...
The mechanism of electro-acupuncture at Shu and Mu acupoints of lung and large intestine meridians for relieving acute gastrointestinal injury in rats with acute pancreatitis
Based on the theory of exterior-interior relationship between the lung and the large intestine, the mechanism of electro-acupuncture at Shu and Mu acuacupoints for relieving gastrointestinal injury of AP rats was explore...
The concept of vaccines first came from Chinese medicine
On July 15, 2018, the State Drug Administration of China issued a notice stating that the production records for freeze-dried human rabies vaccine manufactured by Changchun Changsheng Biotechnology Co., Ltd., could be fa...
Effects of chicory (Cichorium intybus L.) on nonalcoholic fatty liver disease
There is a dramatic increase in the prevalence of nonalcoholic fatty liver disease, which is slowly turning into a pandemic as well as a major challenge across the world. Nonalcoholic fatty liver disease is described as...
In vitro evaluation of transdermal permeation effects of Fu’s cupping therapy via six diffusion kinetics models
In this study, six kinetics models of indomethacin hydrophilic gel patch transdermal in vitro release was established, including zero-level, first-order, Higuchi-level, Ritger-Peppas, Weibull and Hixcon-Crowell dynamic e...